Biopharmaceutical

Sinobiomed Announces New Chief Executive Officer

September 02, 2010

New, Experienced Management Intends to Move Swiftly on Funding, Acquisitions and Corporate Initiatives
 

Biodel Announces Name Change for Lead Product Candidate

September 01, 2010

Currently under review by the U.S. Food and Drug Administration
 

XenoPort Announces Changes to Executive Team

August 26, 2010

William J. Rieflin to resign as President
 

FDA Accepts Sanofi Pasteur's Application to Expand Indication of Menactra® Vaccine to Infants and Toddlers

August 26, 2010

New Indication Seeks to Help Protect Infants and Toddlers Against Meningococcal Disease
 
 

Nabi Biopharmaceuticals Significantly Enhances NicVAX Patent Portfolio

August 24, 2010

Patent Issued for Exclusive Use of NicVAX and Related Nicotine Vaccines to Treat or Prevent Nicotine Addiction
 

Celsion Receives Fast Track Designation for ThermoDox® Development Program to Treat Primary Liver Cancer

August 24, 2010

Supplements Special Protocol Assessment for Global Phase III HEAT Study
 

Additional Phase III clinical trial with Urocidin(TM) expected to commence in 2010

August 19, 2010

Analysis of data from first Phase III clinical trial nearing completion
 

Amarin Corporation Appoints Colin W. Stewart as President and Chief Executive Officer

August 17, 2010

Mr. Stewart has more than 30 years of experience in executive management and commercial positions
 

Pacific Biosciences Expands Into European Union

August 03, 2010

Terry Pizzie Appointed Vice President, Europe
 

Conatus Pharmaceuticals Acquires Pfizer's Idun Subsidiary

July 30, 2010

Former Idun Management team to expand efforts in liver disease and oncology
 

Horizon Pharma, Inc. Announces Results of Phase 3 Study of LODOTRA®

July 23, 2010

Results Demonstrate 12-Month Sustained Efficacy and Safety in Rheumatoid Arthritis
 

Prochymal New Drug Submission Granted Priority Review by Health Canada

July 21, 2010

Health Canada to add first-in-class stem cell therapy to Register of Innovative Drugs providing eight years of market exclusivity
 

FDA Accepts AFREZZA Complete Response Resubmission

July 20, 2010

FDA Sets Target Action Date of December 29, 2010
 

Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer

July 14, 2010

Dr. Brennan has over 10 years experience in business development
 

Kamada Wins FDA Approval for GlassiaTM

July 06, 2010

A New Liquid, Ready-to-Use Treatment for Alpha-1 Antitrypsin Deficie
 

Actelion Introduces First Pulmonary Arterial Hypertension (PAH) Multimedia Mobile Application for Healthcare Professionals

June 10, 2010

Application provides on-the-go disease pathology, diagnosis, treatment information
 

Alnylam Strengthens Management Team with New Key Appointments

June 02, 2010

Appoints Laurence Reid, Ph.D. as SVP, Chief Business Officer
 

Rigel Pharmaceuticals Names Raul Rodriguez President

June 01, 2010

Ryan Maynard and Dolly Vance Promoted to Executive Vice Presidents
 

Horizon Pharma, Inc. Announces FDA Acceptance of DUEXA(R) New Drug Application for Filing

May 26, 2010

FDA's completed review for DUEXA is expected in the first quarter of 2011
 

3-V Biosciences Expands Leadership Team

May 13, 2010

Opens New Facility and Integrates Operations
 

Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development

May 06, 2010

Dr. Pitler brings to Chimerix more than 25 years of experience
 

Dicerna Names Douglas Fambrough as Chief Executive Officer

May 06, 2010

Appointment Strategically Positions Company for Next Phase of Growth
 

AVI BioPharma Appoints David Boyle Interim President and CEO

April 21, 2010

Anthony Chase, Joins AVI Board
 

Positive Phase III Diabetes Data with Lixisenatide Announced by Zealand Pharma's Partner sanofi-aventis

April 15, 2010

Once daily Lixisenatide meets Phase III Study Endpoints in Diabetes
 

VaxGen to Acquire diaDexus in a Stock-for-Stock Merger

April 14, 2010

diaDexus will use cash to fund continued adoption of the PLAC(R) Test
 

Cephalon Completes Acquisition of Swiss Pharmaceutical Company Mepha

April 09, 2010

Acquisition Diversifies Global Pharmaceutical Business
 

Cephalon Completes Acquisition of Ception Therapeutics

April 05, 2010

Acquisition Adds Biologics Asset for Advancement to Phase Three Development
 

Horizon Therapeutics and Nitec Pharma Complete Merger and Combine Businesses

April 01, 2010

Combined company has one approved product and two late-stage candidates
 

Santarus Announces Launch of ZEGERID OTC by Schering-Plough Consumer HealthCare

April 01, 2010

ZEGERID OTC Now Available on Retail Store Shelves in the U.S.
 

Latest News

Popular Topics
Acquisition Agency Animal Health Biopharmaceutical Biotech Business Clinical Management Collaboration Diagnostic Marketing & Communications Medical Device Medical Equipment Merger New Hire New Hires Personnel Pharmaceutical Pharmaceutical Products Pipeline Product Acquisition Product Launch Product Promotion Regulatory Regulatory Approval Research & Development